News | Hypertension Research Center

Why clinical trials matter: Revolutionary new kidney treatments show what UAB can deliver for Alabama patients

Within the past three years, four pivotal clinical trials co-led by UAB’s Dana Rizk, M.D., have completely changed the treatment landscape for IgA nephropathy. “Many of the patients who took part in the trials here had tried and failed many other treatments,” Rizk said. “To know that they now have these new drugs available to them is remarkable.”

How to approach skin care according to your skin type

UAB expert shares her insight and tips on different skin types and what skin care routine is best.

How to safely introduce technology to a tween

Two UAB experts offer guidance on best practices for introducing technology to young teenagers.

Transformational $5 million gift to advance UAB O’Neal Cancer Center Clinical Trials Program

This landmark investment will strengthen the UAB O’Neal Cancer Center’s nationally recognized clinical trials program and expand access to innovative cancer therapies for patients across Alabama and the Southeast.

UAB awarded grants to study atherosclerosis advancement and MYC-driven cancers

UAB researchers Daniel Tyrrell and Han-Fei Ding have received $4.9 million in NIH grants, advancing discoveries that could lead to new treatments for heart disease and aggressive cancers.

Experts share importance of back-to-school checkups

UAB experts urge parents to schedule back-to-school checkups to support children’s health, prevent disease, identify issues early and help students succeed in the classroom.

Microbe exposure and T cells drive anti-carbohydrate antibody production

A study reveals that T cells help develop diverse anti-carbohydrate antibodies after early microbial exposure, offering new insights into immune defense, autoimmune disease, asthma and future therapeutic development.

Study identifies how RNA “switches” could reveal the biology of major depressive disorder

A UAB researcher studied how tiny molecules could influence groups of genes responsible for how brain cells communicate, adapt and respond to stress.

Startup advances novel oral Type 1 diabetes therapy to next phase of human testing

UAB startup TIXiMED advances TIX100, a novel oral Type 1 diabetes therapy, into Phase 1b clinical testing. The TXNIP-targeting drug aims to protect insulin-producing beta cells and address disease progression beyond blood sugar management.

Micromobility safety: Avoiding traumatic brain injuries and facial trauma

Helmets, protective gear and safe riding habits can significantly reduce the risk of serious injuries from bikes, e-scooters and other micromobility vehicles that are popular for summer fun.

First patient in HER2-positive breast cancer clinical trial defies odds and inspires hope in others

Rebecca Hall was diagnosed with leptomeningeal metastasis and was weeks from passing, until she enrolled as the first patient in a clinical trial.

Postpartum weight loss may be easier when eating habits fit a mother’s routine, study finds

The investigators strongly recommend that new mothers interested in a chrononutrition approach should discuss it with their healthcare providers.